p63 the guardian of human reproduction
暂无分享,去创建一个
[1] A. Strasser,et al. DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. , 2012, Molecular cell.
[2] I. Amelio,et al. miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration , 2012, The Journal of cell biology.
[3] A. Levine,et al. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer , 2012, Proceedings of the National Academy of Sciences.
[4] G. Cesareni,et al. Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib , 2012, Nature Medicine.
[5] T. Speed,et al. Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib , 2012, Nature Medicine.
[6] P. Tucci. Caloric restriction: is mammalian life extension linked to p53? , 2012, Aging.
[7] S. Melov,et al. cep-1/p53-dependent dysplastic pathology of the aging C. elegans gonad , 2012, Aging.
[8] V. Smits. EDD induces cell cycle arrest by increasing p53 levels , 2012, Cell cycle.
[9] S. Sinha,et al. ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation , 2012, Development.
[10] M. Olivier,et al. Biological functions of p53 isoforms through evolution: lessons from animal and cellular models , 2011, Cell Death and Differentiation.
[11] A. Mahdi,et al. Regulation of glucose metabolism by p53: Emerging new roles for the tumor suppressor , 2011, Oncotarget.
[12] J. McCubrey,et al. Recent progress in targeting cancer , 2011, Aging.
[13] C. Montagna,et al. Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors , 2011, Oncotarget.
[14] M. Baccarani,et al. Imatinib in chronic myeloid leukemia elderly patients , 2011, Aging.
[15] U. Moll,et al. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis , 2011, Cell Death and Differentiation.
[16] B. Joseph,et al. TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death , 2011, Oncotarget.
[17] David F. Callen,et al. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome , 2011, Oncotarget.
[18] P. Madureira,et al. DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death , 2011, Oncotarget.
[19] I. Amelio,et al. The sterile alpha-motif (SAM) domain of p63 binds in vitro monoasialoganglioside (GM1) micelles. , 2011, Biochemical pharmacology.
[20] G. Melino,et al. Cell death pathology: perspective for human diseases. , 2011, Biochemical and biophysical research communications.
[21] I. Amelio,et al. Cell death pathology: cross-talk with autophagy and its clinical implications. , 2011, Biochemical and biophysical research communications.
[22] M. Napoli,et al. Wiring the oncogenic circuitry: Pin1 unleashes mutant p53 , 2011, Oncotarget.
[23] C. Chien,et al. The p53 target Wig-1: a regulator of mRNA stability and stem cell fate? , 2011, Cell Death and Differentiation.
[24] M. Dobbelstein,et al. Non-hominid TP63 lacks retroviral LTRs but contains a novel conserved upstream exon , 2011, Cell cycle.
[25] V. Dötsch,et al. Quality control in oocytes: Domain-domain interactions regulate the activity of p63 , 2011, Cell cycle.
[26] H. Tseng,et al. Intracellular zinc release-activated ERK-dependent GSK-3β–p53 and Noxa–Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury , 2011, Cell Death and Differentiation.
[27] L. Mayo,et al. ΔNp63α regulates keratinocyte proliferation by controlling PTEN expression and localization , 2011, Cell Death and Differentiation.
[28] M. Jiang,et al. SUMO-specific protease 2 in Mdm2-mediated regulation of p53 , 2011, Cell Death and Differentiation.
[29] A. Jochemsen,et al. Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX , 2011, Cell Death and Differentiation.
[30] R. Mantovani,et al. NF-Y joins E2Fs, p53 and other stress transcription factors at the apoptosis table , 2011, Cell Death and Disease.
[31] U. Moll,et al. Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors , 2011, Cell Death and Disease.
[32] G. Melino,et al. ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis , 2011, Cell Death and Differentiation.
[33] L. Zhang,et al. Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways , 2011, Cell Death and Differentiation.
[34] B. Pützer,et al. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria , 2011, Cell Death and Differentiation.
[35] R. Jänicke,et al. Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21WAF1/CIP1 , 2011, Cell Death and Differentiation.
[36] A. Furlan,et al. Abl interconnects oncogenic Met and p53 core pathways in cancer cells , 2011, Cell Death and Differentiation.
[37] B. Kim,et al. PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation , 2011, Cell Death and Differentiation.
[38] S. de Jong,et al. Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway , 2011, Cell Death and Disease.
[39] A. Holoubek,et al. Decitabine-induced apoptosis is derived by Puma and Noxa induction in chronic myeloid leukemia cell line as well as in PBL and is potentiated by SAHA , 2011, Molecular and Cellular Biochemistry.
[40] A. Ciechanover,et al. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms , 2011, Cell Death and Differentiation.
[41] L. Ellisen,et al. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity , 2011, Oncotarget.
[42] Aubrey E. Hill,et al. Spontaneous inactivating p53 mutations and the “selfish cell” , 2011, Aging.
[43] Yanping Zhang,et al. The RP-Mdm2-p53 Pathway and Tumorigenesis , 2011, Oncotarget.
[44] S. Knapp,et al. DNA Damage in Oocytes Induces a Switch of the Quality Control Factor TAp63α from Dimer to Tetramer , 2011, Cell.
[45] U. Moll,et al. Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes , 2011, Proceedings of the National Academy of Sciences.
[46] M. Blagosklonny. Cell cycle arrest is not senescence , 2011, Aging.
[47] K. Sabapathy,et al. Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo , 2011, Cell Death and Differentiation.
[48] D. Lane,et al. p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage , 2011, Cell Death and Differentiation.
[49] E. Rodríguez-Aznar,et al. Repression of Puma by Scratch2 is required for neuronal survival during embryonic development , 2011, Cell Death and Differentiation.
[50] V. Graupner,et al. Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level , 2011, Cell Death and Differentiation.
[51] W. B. Derry,et al. The EEL-1 ubiquitin ligase promotes DNA damage-induced germ cell apoptosis in C. elegans , 2011, Cell Death and Differentiation.
[52] J. Luk,et al. Mortalin–p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy , 2011, Cell Death and Differentiation.
[53] V. Dulic,et al. Be quiet and you'll keep young: does mTOR underlie p53 action in protecting against senescence by favoring quiescence? , 2011, Aging.
[54] G. D’Orazi,et al. HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation , 2011, Aging.
[55] C. Harris,et al. p53 governs telomere regulation feedback too, via TRF2 , 2011, Aging.
[56] Antoine M. van Oijen,et al. A single-molecule characterization of p53 search on DNA , 2010, Proceedings of the National Academy of Sciences.
[57] A. Fersht,et al. Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA , 2010, Proceedings of the National Academy of Sciences.
[58] A. Chatterjee,et al. Regulation of ΔNp63α by NFκΒ , 2010, Cell cycle.
[59] N. Danial,et al. Noxa: a sweet twist to survival and more. , 2010, Molecular cell.
[60] Seung-Moo Noh,et al. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice. , 2010, The Journal of clinical investigation.
[61] Yiping Huang,et al. Phospho-ΔNp63α/Rpn13-dependent regulation of LKB1 degradation modulates autophagy in cancer cells , 2010, Aging.
[62] Anton Berns,et al. Cancer: The blind spot of p53 , 2010, Nature.
[63] Youngho Seo,et al. Selective activation of p53-mediated tumour suppression in high-grade tumours , 2010, Nature.
[64] P. Hau,et al. The requirement of p53 for maintaining chromosomal stability during tetraploidization , 2010, Oncotarget.
[65] A. Villunger,et al. PUMA-mediated tumor suppression: A tale of two stories , 2010, Cell cycle.
[66] Wei Gu,et al. p53 post-translational modification: deregulated in tumorigenesis. , 2010, Trends in molecular medicine.
[67] I. Amelio,et al. Skn-1a/Oct-11 and ΔNp63α exert antagonizing effects on human keratin expression. , 2010, Biochemical and biophysical research communications.
[68] Wenyi Wei,et al. Novel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction , 2010, Oncotarget.
[69] Francisco J. Sánchez-Rivera,et al. Stage-specific sensitivity to p53 restoration during lung cancer progression , 2010, Nature.
[70] K. Tanaka,et al. Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticus , 2010, Cell Death and Disease.
[71] F. Gage,et al. Puma is required for p53-induced depletion of adult stem cells , 2010, Nature Cell Biology.
[72] D. Trinh,et al. Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosis , 2010, Oncotarget.
[73] D. Trinh,et al. Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosisy as a Target for Cancer Therapy , 2010 .
[74] M. Pajic,et al. Tumor-initiating cells are not enriched in cisplatin-surviving BRCA1;p53-deficient mammary tumor cells in vivo , 2010, Cell cycle.
[75] Y. Shyr,et al. Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation , 2010, Cell Death and Disease.
[76] H. Ananthaswamy,et al. Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence , 2010, Cell cycle.
[77] K. Ryan,et al. Phosphorylation of Puma modulates its apoptotic function by regulating protein stability , 2010, Cell Death and Disease.
[78] Frédérick A. Mallette,et al. SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence , 2010, Aging.
[79] Z. Darżynkiewicz. Another "Janus paradox" of p53: induction of cell senescence versus quiescence , 2010, Aging.
[80] G. Sal,et al. p53-family proteins and their regulators: hubs and spokes in tumor suppression , 2010, Cell Death and Differentiation.
[81] G. Nilsson,et al. Pro-apoptotic Bax is the major and Bak an auxiliary effector in cytokine deprivation-induced mast cell apoptosis , 2010, Cell Death and Disease.
[82] V. Sée,et al. p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma , 2010, Cell Death and Disease.
[83] Michael Hölzel,et al. The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword , 2010, Oncotarget.
[84] R. Knight,et al. p73 and p63 regulate the expression of fibroblast growth factor receptor 3. , 2010, Biochemical and biophysical research communications.
[85] C. Brisken,et al. Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates , 2010, Cell Death and Differentiation.
[86] S. Kumar,et al. A potential role for NEDD1 and the centrosome in senescence of mouse embryonic fibroblasts , 2010, Cell Death and Disease.
[87] I. B. Borel Rinkes,et al. Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa , 2010, British Journal of Cancer.
[88] K. Vousden,et al. p53-mediated induction of Noxa and p53AIP1 requires NFκB , 2010 .
[89] A. Knebel,et al. JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis , 2010, Cell Death and Disease.
[90] N. Reich,et al. Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding , 2010, Cell Death and Differentiation.
[91] A. Tedeschi,et al. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation , 2010, Cell Death and Differentiation.
[92] E. Candi,et al. The microRNA and p53 families join forces against cancer , 2010, Cell Death and Differentiation.
[93] J. Prehn,et al. BH3-only proteins BIM and PUMA in the regulation of survival and neuronal differentiation of newly generated cells in the adult mouse hippocampus , 2010, Cell Death and Disease.
[94] Nektarios Tavernarakis,et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy , 2010, Cell Death and Disease.
[95] G. Cesareni,et al. Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death , 2009, Nature Medicine.
[96] L. Zhang,et al. IRF-1 transcriptionally up-regulates PUMA which mediates the mitochondrial apoptotic pathway in IRF-1 induced apoptosis in cancer cells , 2009, Cell Death and Differentiation.
[97] Y. Liu,et al. p53 regulates hematopoietic stem cell quiescence. , 2009, Cell stem cell.
[98] Yiping Huang,et al. ATM kinase is a master switch for the ΔNp63α phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage , 2008 .
[99] Hua Lu,et al. Phosphorylation and Stabilization of TAp63γ by IκB Kinase-β* , 2008, Journal of Biological Chemistry.
[100] Eduardo Sontag,et al. Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.
[101] F. McKeon,et al. p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia , 2007, Cell.
[102] Karen H. Vousden,et al. p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.
[103] G. Livera,et al. The role of p63 in germ cell apoptosis in the developing testis , 2007, Journal of cellular physiology.
[104] M. Kretz,et al. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. , 2006, Genes & development.
[105] A. Yang,et al. p63 protects the female germ line during meiotic arrest , 2006, Nature.
[106] C. Croce,et al. The E3 ubiquitin ligase Itch controls the protein stability of p63 , 2006, Proceedings of the National Academy of Sciences.
[107] D. Lane,et al. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress , 2006, Cell Death and Differentiation.
[108] J. Mestan,et al. Allosteric inhibitors of Bcr-abl–dependent cell proliferation , 2006, Nature chemical biology.
[109] G. Livera,et al. p63 expression pattern in foetal and neonatal gonocytes after irradiation and role in the resulting apoptosis by using p63 knockout mice , 2006, International journal of radiation biology.
[110] F. McKeon,et al. DNA-Binding and Transactivation Activities Are Essential for TAp63 Protein Degradation , 2005, Molecular and Cellular Biology.
[111] O. Hovatta,et al. Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture. , 2005, Reproduction.
[112] K. Tsai,et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage , 2002, Nature.
[113] W. B. Derry,et al. Caenorhabditis elegans p53: Role in Apoptosis, Meiosis, and Stress Resistance , 2001, Science.
[114] M. Belvin,et al. Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53 , 2000, Cell.
[115] Christopher P. Crum,et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.
[116] H. Vogel,et al. p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.
[117] Gerry Melinoa,et al. Loss of p 63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer , 2014 .
[118] P. Madureira,et al. binding to p 53 on the p 21 WAF 1 / CIP 1 promoter blocks transcription resulting in cell death , 2012 .
[119] Y. Shaul,et al. c-Abl tyrosine kinase in the DNA damage response: cell death and more , 2011, Cell Death and Differentiation.
[120] David P. Lane,et al. Translating p53 into the clinic , 2010, Nature Reviews Clinical Oncology.
[121] W. Gu,et al. The multiple levels of regulation by p53 ubiquitination , 2010, Cell Death and Differentiation.
[122] Y. Shaul,et al. Ubiquitin-independent p53 proteasomal degradation , 2010, Cell Death and Differentiation.
[123] J. Marine,et al. Mdm2-mediated ubiquitylation: p53 and beyond , 2010, Cell Death and Differentiation.
[124] Yiping Huang,et al. ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage. , 2008, Cell cycle.
[125] R. Wurm,et al. Normal tissue radiosensitivity--how important is it? , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).
[126] S. Sinha,et al. Np 63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation , 2022 .
[127] A. Bradley,et al. p 63 is a p 53 homologue required for limband epidermalmorphogenesis , 2022 .